Lg chem, ltd. (20240300944). NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR simplified abstract
NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR
Organization Name
Inventor(s)
Joong Heui Cho of Daejeon (KR)
Young Shin Kwak of Daejeon (KR)
Gyeong Hwan Kim of Daejeon (KR)
NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240300944 titled 'NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR
The present invention relates to a novel compound as a protein kinase inhibitor, a ron inhibitor in particular.
- Simplified Explanation:
This patent application discusses a new compound that acts as a protein kinase inhibitor, specifically targeting ron.
- Key Features and Innovation:
- Novel compound as a protein kinase inhibitor - Specific focus on ron inhibition
- Potential Applications:
- Treatment of diseases related to protein kinases - Potential use in cancer therapy
- Problems Solved:
- Targeting specific protein kinases for therapeutic purposes - Addressing the need for more effective kinase inhibitors
- Benefits:
- Improved treatment options for diseases involving protein kinases - Potential for more targeted and effective cancer therapies
- Commercial Applications:
- Potential use in pharmaceuticals for developing new treatments - Market implications in the field of cancer research and therapy
- Questions about Protein Kinase Inhibitors:
1. What are the potential side effects of using protein kinase inhibitors in treatment? - Protein kinase inhibitors can have various side effects, including gastrointestinal issues, skin problems, and cardiovascular complications.
2. How do protein kinase inhibitors differ from other types of cancer treatments? - Protein kinase inhibitors target specific enzymes involved in cancer cell growth, offering a more targeted approach compared to traditional chemotherapy.
- Frequently Updated Research:
- Stay updated on the latest advancements in protein kinase inhibitors and their applications in cancer therapy.
Original Abstract Submitted
the present invention relates to a novel compound as a protein kinase inhibitor, a ron inhibitor in particular.
